Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.


AIM To study the long-term visual and anatomical outcomes of antivascular endothelial growth factor (VEGF) monotherapy for the treatment of patients with retinal angiomatous proliferation (RAP). METHODS Retrospective review of patients who were diagnosed as having AMD and RAP lesions, and who received anti-VEGF injections as the only mode of therapy… (More)
DOI: 10.1136/bjo.2009.167627


6 Figures and Tables